CRISPR-Cas9 is a revolutionary tool in part because of its versatility: created by bacteria to chew up viruses, it works equally well in human cells to do all sorts of genetic tricks, including cutting and pasting DNA, making pinpoint mutations and activating or inactivating a gene.
UC Berkeley researchers have now made it even more versatile by giving it an “on” switch, allowing users to keep the Cas9 gene editor turned off in all cells except its designated target.
The redesigned Cas9 enzyme — which the researchers refer to as ProCas9 — is fully functional except for containing a length of protein that needs to be snipped before the enzyme can bind and cut DNA. If scientists insert a short length of protein that can be cut only by a particular enzyme, such as one used exclusively by cancer cells or an infectious virus or bacteria, that enzyme becomes a trigger to turn on Cas9.
ProCas9 essentially “senses” the type of cell it’s in based on the protein-cutting enzyme — a so-called protease — present.
“This is an extra layer of security you could put on the molecule to ensure accurate cutting,” said David Savage, a UC Berkeley associate professor of molecular and cell biology.
It also endows the Cas9 protein with programmable inputs in addition to its programmable outputs.
“There are a lot of proteases that regulate signaling pathways in cells, transform normal cells into cancer cells, and are involved in pathogen infection,” said Savage. “If we can sense these signals, we can tap into and respond accordingly to these important pathways.”
In the study, Savage and his colleagues demonstrated protease control of Cas9 by making it sensitive to both plant and human viruses, such as West Nile Virus. In the future, they believe this sort of technology could be used to import the CRISPR-Cas9 bacterial immune system into plants to help them fend off damaging viral pathogens.
The study by researchers from UC Berkeley and the Gladstone Institutes in San Francisco will be published online Jan. 10 in the journal Cell.
Stripping Cas9 to its essentials
Savage’s original research goal was to pare down the Cas9 protein — the “scissors” that actually snip DNA to do gene editing — to its simplest parts, to get the most robust gene editor possible. The simpler it is, the easier it is to work with and to ferry into cells.
“We know the Cas proteins are complex and that they have all sorts of regulation that is critical to how they function in a bacterial immune system,” he said. “The broad goal of our work is to tame them for use in humans and to strip away the unnecessary things not relevant for genome editing.”
In particular, he wanted to redesign Cas9 so it would be easier to attach other proteins. This would allow Cas9 to carry proteins with a variety of functions to the right spot on DNA. These are known as fusion proteins, promising variants of which can alter gene expression or, in the case of a technology known as base-editing, alter one base or nucleotide in the DNA with pinpoint accuracy.
The technique he used to reengineer Cas9, called circular permutation, has never been tried on a protein as complex as Cas9. Circular permutation involves taking the amino-acid string of the Cas9 protein and cutting it, switching the order of the two segments, and then allowing it to fold into a new 3D configuration. He did this for all possible ways of cutting the protein into two pieces.
While you might think this would completely wreck the protein, in about 10 percent of cases, the new protein still worked, as if he had merely rearranged the protein’s subunits in a different way that did not affect how they functioned. This may work because, as CRISPR-Cas9 inventor Jennifer Doudna and her colleagues have shown, the Cas9 protein complex is highly flexible and moves around as it grabs onto guide RNA, binds to DNA and moves into position to cut DNA strands.
Savage is currently exploring some Cas9 rearrangements that may provide a better scaffold for fusion proteins, bringing them closer to the DNA strand they are targeting.
In the process of rearranging the Cas9 scaffold, he found, serendipitously, that the way in which he reconnected the two protein segments made a difference.
“When we cut the protein and moved the old piece to a new place within the protein, the system became very sensitive to how you linked the two fragments together,” he said. “We realized that we could use that sensitivity to engineer the protein to have protease recognition sites.”
The study shows that “we’re not stuck with what nature gave us with regards to genome-editing proteins,” he said. “These proteins can be elaborately optimized and turned into scaffolds not found in nature but possessing the right properties for use in human cells.”
The Latest on: Gene editing
via Google News
The Latest on: Gene editing
- Engineers create nanoparticles that deliver gene-editing tools to specific tissues and organson October 8, 2020 at 5:51 am
One of the most remarkable recent advances in biomedical research has been the development of highly targeted gene-editing methods such as CRISPR that can add, remove, or change a gene within a cell ...
- Nobel Prize in Chemistry Awarded to First All-Female Team for CRISPR Gene Editingon October 8, 2020 at 5:28 am
Jennifer A. Doudna (left) and Emmanuelle Charpentier, shown in 2016. Jennifer Doudna was sound asleep when her phone began buzzing, so she missed the first few calls. When the incessant ringing ...
- 2 scientists win Nobel chemistry prize for gene-editing toolon October 8, 2020 at 1:19 am
The Nobel Prize in chemistry went to two researchers Wednesday for a gene-editing tool that has revolutionized science by providing a way to alter DNA, the code of life — technology already being used ...
- Nobel Prize for chemistry honors exquisitely precise gene-editing technique, CRISPR – a gene engineer explains how it workson October 7, 2020 at 9:14 pm
Researchers have been able to manipulate large chunks of genetic code for almost 50 years. But it is only within the past decade that they have been able to do it with exquisite precision – adding, de ...
- 2 women win Nobel Prize in chemistry for gene-editing methodon October 7, 2020 at 8:11 pm
Two scientists won the Nobel Prize in chemistry Wednesday for developing a way of editing genes that could one day cure inherited diseases. Frenchwoman Emmanuelle Charpentier and American Jennifer ...
- Gene-editing tool CRISPR wins the chemistry Nobelon October 7, 2020 at 3:11 pm
A gene-editing tool developed just eight years ago that has “revolutionized the life sciences” nabbed the 2020 Nobel Prize in chemistry.
- Gene-Editing CRISPR Pioneers Get a Well-Deserved Nobel Prizeon October 7, 2020 at 1:12 pm
On Wednesday, the Royal Swedish Academy of Sciences awarded the Nobel Prize in Chemistry to scientists Emmanuelle Charpentier and Jennifer Doudna for their pivotal roles in discovering CRISPR/Cas9, an ...
- Two women just won the Nobel Prize for their work on the gene-editing technique CRISPRon October 7, 2020 at 1:04 pm
On Wednesday, a pair of female scientists became the first pair of women to solely share a Nobel Prize for a scientific discovery and become only the fifth and sixth women to win the Nobel in ...
- Gene-editing CRISPR technique can help us cut emissions from farmingon October 7, 2020 at 11:57 am
There are risks to using CRISPR, but also to not embracing it, because it will be much harder to reduce greenhouse gas emissions from food production without gene editing ...
- Pioneers of revolutionary CRISPR gene editing win chemistry Nobelon October 7, 2020 at 9:34 am
Emmanuelle Charpentier and Jennifer Doudna share the award for developing the precise genome-editing technology.
via Bing News